Who We Serve
The Hemophilia Foundation of Maryland (HFM) serves patients, caregivers, and loved ones affected by rare bleeding disorders. HFM maintains an ongoing dialogue with community members, stakeholders, and colleagues who rely on our expertise. Our outreach development, educational programs, informational literature, support services and patient referral operations empower individuals with blood or bleeding disorders and their families to succeed in their pursuit for better health and quality of life. In addition to our programs and events for members, we champion research and provide educational resources that empower those with bleeding disorders and their loved ones, and advocate for legislative measures at the state and local levels to ensure uninterrupted access to healthcare services. Our foundation offers educational programs, fundraisers and general events to support and advance treatment and patient care.
Who We Serve
HFM is at the nexus of advocacy, education & community.
The Hemophilia Foundation of Maryland proudly extends its support to bleeding disorder patients across all 23 counties in Maryland, as well as Baltimore City.
This commitment encompasses patients residing in neighboring states who receive care at the Johns Hopkins Hemophilia Treatment Center, as well as those under the care of the Children’s National Medical Center and Georgetown Hemophilia Treatment Centers.
HFM addresses the following:
- Hemophilia A (Factor VIII Deficiency)
- Hemophilia B (Factor IX Deficiency)
- Hemophilia C (Factor XI Deficiency)
- von Willebrand Disorder
- Factor VII Deficiency
- Platelet Disorders
- ... and other rare bleeding disorders
We encourage patient caregivers
Our educational outreach extends to a broad medical audience. We deliver education on bleeding disorders to pediatricians, OB-GYNs, and other healthcare professionals, equipping them with the knowledge to identify bleeding disorder symptoms and ensure their patients receive the necessary care. We also foster research by urging scientists within the bleeding disorder treatment network to explore new avenues for enhancing patient care.